Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-05 @ 6:32 PM
Study NCT ID:
NCT05491057
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-08-08
First Post:
2022-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment Patterns of Neratinib in HER2+ EBC in China
Sponsor:
Pierre Fabre Medicament
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PF008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None